Category:

The U.S. Treasury...imposed sanctions on three Chinese men accused of illegally trafficking fentanyl, acting three weeks after President Donald Trump accused Beijing of reneging on pledges to stem a flood of the highly addictive synthetic opioid into the United States...The trio included a father and son indicted in Ohio...on charges of producing and smuggling fentanyl and fentanyl-related substances. The third man was indicted on similar charges in Mississippi...The United States had pressed China to arrest Fujing Zheng and his father, Guanghua Zheng, and Xiaobing Yan since their indictments...The three men were designated as foreign drug kingpins by the U.S. Treasury Department’s Office of Foreign Assets Control under a law that freezes any property they control in the United States and bars American citizens from doing business with those properties...The three also face penalties ranging from civil fines of up to $1.1 million per violation to more serious criminal penalties...READ MORE

Diverting border security resources to address the “humanitarian need” of migrants is leading to record-high levels of illicit drug smuggling across the U.S.-Mexico border, said James W. Carroll, director of the U.S. Office of Drug Control Policy...Carroll said, “I couldn’t tell you how bad this is. Seizures are down, and it’s not because there are less drugs coming in. It’s because their attention has to be diverted because of the humanitarian need, but what that means is more drugs are coming in than ever before.”...READ MORE

William Husel voluntarily surrendered to authorities in Columbus and was charged in 25 deaths following a six-month investigation by the Franklin County Prosecutor's Office. The patient deaths exposed a stunning case of medical oversight and alleged medical malpractice, and called into question how repeated failures potentially involving 30 or more employees could have gone unchecked for so long...Husel faces 15 years to life in prison per count if convicted. O'Brien said that the doses ordered by the doctor in the 25 deaths "could not support any legitimate medical purpose." Although nurses and pharmacists followed Husel's orders, the doctor remains the main focus of the criminal investigation...Also named in the various civil suits are the Mount Carmel Health System and some pharmacists and nurses. What remains unclear is how Husel could circumvent apparent rules that would require him to order medications through an in-house pharmacy team and then convince a nurse to administer the drug...READ MORE

The U.S. Treasury Department...placed sanctions on Goldpharma, an Argentina-based network of online pharmacies that it said contributed to the opioid crisis by selling clandestinely produced narcotics to customers in the United States...The Treasury’s Office of Foreign Assets Control also designated eight Argentine nationals and nine entities located in Argentina, Colombia, Canada, Britain and the Netherlands for their roles in Goldpharma...“The Goldpharma network illustrates the sophisticated tactics drug traffickers and money launderers use to capitalize on the Internet and online pharmacy sites to sell highly addictive illicit narcotics around the world,” said Sigal Mandelker, Treasury under secretary for terrorism and financial intelligence...READ MORE

About five years ago, Nevada started taking high-profile steps toward tackling the opioid crisis. There were bills to curb doctor-shopping and over-prescribing in 2015 and 2017, a statewide opioid summit in 2016 and a cascade of lawsuits against opioid manufacturers from the state and local governments in the past few years...But has the growing awareness and response made a dent in the epidemic?...Scores of law enforcement, treatment professionals, elected officials and others gathered in Las Vegas this week for a two-day conference where they assessed progress and exchanged ideas on how to better tackle opioid abuse...Here are some takeaways from the event:...READ MORE

A unit of Insys Therapeutics Inc pleaded guilty...to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication...The plea...by the Chandler, Arizona-based Insys’ operating subsidiary, came in one of the few criminal prosecutions to date of a corporation accused of helping fuel the nation’s deadly opioid epidemic...Insys is facing growing financial pressures as a result of the U.S. probe and a decline in sales of its flagship fentanyl pain product, Subsys, which it has said could prompt the company to seek bankruptcy protection...Beyond the plea by subsidiary Insys Pharma Inc, Insys has also entered into a five-year deferred prosecution agreement with the government and agreed to pay $30 million in the criminal case and $195 million to resolve civil claims...READ MORE

Illicit chemical knock-offs of the extremely potent opioid fentanyl would be put permanently in the same legal class as heroin to boost prosecutions of traffickers and makers of the drugs, under a proposal to be unveiled...by the U.S. Drug Enforcement Administration...The new classification is meant to help fight a proliferation of chemical look-alikes of fentanyl, known as analogues...DEA Acting Chief Operations Officer Greg Cherundolo is set to go before a Senate committee...to propose that Congress make the measure permanent so that cases against various analogues will not be undercut when the temporary ban lapses...READ MORE

Surescripts is upping its battle with Amazon-owned PillPack, accusing a third company of providing PillPack with patient prescription information “fraudulently,” and turning the matter over to the FBI. It’s the latest in a series of moves that could make it harder for Amazon to enter the prescription drug market...PillPack found a way to access its patients’ prescription information via a third-party called ReMy Health...Surescripts, which contracts with ReMy, said this represents “unauthorized access” to its network...READ MORE

A federal judge...tossed the convictions of a co-owner and former employee of a Massachusetts compounding pharmacy accused of conspiring to help it evade regulatory oversight before its drugs caused a deadly 2012 fungal meningitis outbreak...U.S. District Judge Richard Stearns in Boston ruled that New England Compounding Center co-owner Gregory Conigliaro and former employee Sharon Carter did not have fair warning their actions could subject them to prosecution...Jurors convicted Conigliaro and Carter of conspiring to defraud the U.S. Food and Drug Administration by misleading it into thinking NECC was operating like a conventional pharmacy and not like a drug manufacturer...State-regulated compounding pharmacies produce customized drugs pursuant to patient-specific prescriptions to address individual needs. But prosecutors said NECC was actually a drug manufacturer making medications in bulk...READ MORE

Teva Pharmaceutical Industries Ltd said...it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic...Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced...The trial...was set to begin on Tuesday...Oklahoma Attorney General Mike Hunter has alleged that J&J and Teva, along with OxyContin maker Purdue Pharma LP, carried out deceptive marking campaigns that downplayed opioids’ addictive risks while overstating their benefits...READ MORE